{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:26:17Z","timestamp":1779200777802,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1038\/s41440-022-01045-5","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T01:02:49Z","timestamp":1665709369000},"page":"100-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Importance of dietary salt restriction for patients with primary aldosteronism during treatment with mineralocorticoid receptor antagonists: The potential importance of post-treatment plasma renin levels"],"prefix":"10.1038","volume":"46","author":[{"given":"Yuichi","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rika","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Sada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Ozeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koro","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"1045_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"1045_CR2","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u2013300.","journal-title":"J Am Coll Cardiol"},{"key":"1045_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"1045_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1210\/jc.2008-2116","volume":"94","author":"E Born-Frontsberg","year":"2009","unstructured":"Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn\u2019s Registry. J Clin Endocrinol Metab. 2009;94:1125\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"1045_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, et al. Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 2018;71:530\u20137.","journal-title":"Hypertension"},{"key":"1045_CR6","doi-asserted-by":"crossref","unstructured":"Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327\u201359.","DOI":"10.1507\/endocrj.EJ21-0508"},{"key":"1045_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"GL Hundemer","year":"2018","unstructured":"Hundemer GL, Curhan GC, Yozamp N, Wang M, Vaidya A. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6:51\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1045_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.jhh.1001307","volume":"16","author":"T Tanaka","year":"2002","unstructured":"Tanaka T, Okamura T, Miura K, Kadowaki T, Ueshima H, Nakagawa H, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16:97\u2013103.","journal-title":"J Hum Hypertens"},{"key":"1045_CR9","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"1045_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ki.1992.39","volume":"41","author":"HA Bock","year":"1992","unstructured":"Bock HA, Hermle M, Brunner FP, Thiel G. Pressure dependent modulation of renin release in isolated perfused glomeruli. Kidney Int. 1992;41:275\u201380.","journal-title":"Kidney Int"},{"key":"1045_CR11","first-page":"F486","volume":"260","author":"JN Lorenz","year":"1991","unstructured":"Lorenz JN, Weihprecht H, Schnermann J, Sk\u00f8tt O, Briggs JP. Renin release from isolated juxtaglomerular apparatus depends on macula densa chloride transport. Am J Physiol. 1991;260:F486\u201393.","journal-title":"Am J Physiol"},{"key":"1045_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7326\/0003-4819-98-5-817","volume":"98","author":"TA Kotchen","year":"1983","unstructured":"Kotchen TA, Luke RG, Ott CE, Galla JH, Whitescarver S. Effect of chloride on renin and blood pressure responses to sodium chloride. Ann Intern Med. 1983;98:817\u201322.","journal-title":"Ann Intern Med"},{"key":"1045_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.RES.54.1.1","volume":"54","author":"RH Freeman","year":"1984","unstructured":"Freeman RH, Davis JO, Villarreal D. Role of renal prostaglandins in the control of renin release. Circ Res. 1984;54:1\u20139.","journal-title":"Circ Res"},{"key":"1045_CR14","first-page":"F418","volume":"244","author":"U Kopp","year":"1983","unstructured":"Kopp U, DiBona GF. Interaction of renal beta 1-adrenoceptors and prostaglandins in reflex renin release. Am J Physiol. 1983;244:F418\u201324.","journal-title":"Am J Physiol"},{"key":"1045_CR15","first-page":"F562","volume":"258","author":"G Frindt","year":"1990","unstructured":"Frindt G, Sackin H, Palmer LG. Whole-cell currents in rat cortical collecting tubule: low-Na diet increases amiloride-sensitive conductance. Am J Physiol. 1990;258:F562\u20137.","journal-title":"Am J Physiol"},{"key":"1045_CR16","first-page":"F753","volume":"253","author":"S Sansom","year":"1987","unstructured":"Sansom S, Muto S, Giebisch G. Na-dependent effects of DOCA on cellular transport properties of CCDs from ADX rabbits. Am J Physiol. 1987;253:F753\u20139.","journal-title":"Am J Physiol"},{"key":"1045_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/ki.1985.154","volume":"28","author":"M Hropot","year":"1985","unstructured":"Hropot M, Fowler N, Karlmark B, Giebisch G. Tubular action of diuretics: distal effects on electrolyte transport and acidification. Kidney Int. 1985;28:477\u201389.","journal-title":"Kidney Int"},{"key":"1045_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/ki.1991.43","volume":"39","author":"BD Rose","year":"1991","unstructured":"Rose BD. Diuretics. Kidney Int. 1991;39:336\u201352.","journal-title":"Kidney Int"},{"key":"1045_CR19","first-page":"F1269","volume":"255","author":"BA Stanton","year":"1988","unstructured":"Stanton BA, Kaissling B. Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport. Am J Physiol. 1988;255:F1269\u201375.","journal-title":"Am J Physiol"},{"key":"1045_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s42000-019-00167-9","volume":"19","author":"S Fountoulakis","year":"2020","unstructured":"Fountoulakis S, Papanastasiou L, Voulgaris N, Kounadi T, Markou A, Chrousos GP, et al. Salt intake in mineralocorticoid receptor antagonist-treated primary aldosteronism: foe or ally? Hormones (Athens). 2020;19:223\u201332.","journal-title":"Hormones (Athens)"},{"key":"1045_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","volume":"62","author":"GP Rossi","year":"2013","unstructured":"Rossi GP, Cesari M, Cuspidi C, Maiolino G, Cicala MV, Bisogni V, et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension 2013;62:62\u20139.","journal-title":"Hypertension"},{"key":"1045_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","volume":"60","author":"M Reincke","year":"2012","unstructured":"Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A, et al. Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry. Hypertension 2012;60:618\u201324.","journal-title":"Hypertension"},{"key":"1045_CR23","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1056\/NEJMra000050","volume":"345","author":"KT Weber","year":"2001","unstructured":"Weber KT. Aldosterone in congestive heart failure. N. Engl J Med. 2001;345:1689\u201397.","journal-title":"N. Engl J Med"},{"key":"1045_CR24","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006;295:2638\u201345.","journal-title":"JAMA"},{"key":"1045_CR25","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/0002-9378(75)90495-0","volume":"123","author":"AM Michelakis","year":"1975","unstructured":"Michelakis AM, Yoshida H, Dormois JC. Plasma renin activity and plasma aldosterone during the normal menstrual cycle. Am J Obstet Gynecol. 1975;123:724\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"1045_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1210\/jcem-44-1-69","volume":"44","author":"MH Weinberger","year":"1977","unstructured":"Weinberger MH, Kramer NJ, Grim CE, Petersen LP. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women. J Clin Endocrinol Metab. 1977;44:69\u201377.","journal-title":"J Clin Endocrinol Metab"},{"key":"1045_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/NEJM200101043440101","volume":"344","author":"FM Sacks","year":"2001","unstructured":"Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N. Engl J Med. 2001;344:3\u201310.","journal-title":"N. Engl J Med"},{"key":"1045_CR28","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1056\/NEJMoa2105675","volume":"385","author":"B Neal","year":"2021","unstructured":"Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, et al. Effect of salt substitution on cardiovascular events and death. N. Engl J Med. 2021;385:1067\u201377.","journal-title":"N. Engl J Med"},{"key":"1045_CR29","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.120.050371","volume":"143","author":"T Filippini","year":"2021","unstructured":"Filippini T, Malavolti M, Whelton PK, Naska A, Orsini N, Vinceti M. Blood pressure effects of sodium reduction: dose-response meta-analysis of experimental studies. Circulation 2021;143:1542\u201367.","journal-title":"Circulation"},{"key":"1045_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0140-6736(11)61174-4","volume":"378","author":"FJ He","year":"2011","unstructured":"He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet 2011;378:380\u20132.","journal-title":"Lancet"},{"key":"1045_CR31","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3945\/an.115.011684","volume":"7","author":"S McGuire","year":"2016","unstructured":"McGuire S. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Washington, DC: US Departments of Agriculture and Health and Human Services, 2015. Adv Nutr. 2016;7:202\u20134.","journal-title":"Adv Nutr"},{"key":"1045_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association\u2019s strategic Impact Goal through 2020 and beyond. Circulation 2010;121:586\u2013613.","journal-title":"Circulation"},{"key":"1045_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158:825\u201330.","journal-title":"Ann Intern Med"},{"key":"1045_CR34","doi-asserted-by":"publisher","first-page":"E1192","DOI":"10.1503\/cmaj.180194","volume":"190","author":"SW Tobe","year":"2018","unstructured":"Tobe SW, Stone JA, Anderson T, Bacon S, Cheng AYY, Daskalopoulou SS, et al. Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update. CMAJ 2018;190:E1192\u2013e206.","journal-title":"CMAJ"},{"key":"1045_CR35","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1056\/NEJMoa0907355","volume":"362","author":"K Bibbins-Domingo","year":"2010","unstructured":"Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N. Engl J Med. 2010;362:590\u20139.","journal-title":"N. Engl J Med"},{"key":"1045_CR36","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.amjcard.2017.07.068","volume":"120","author":"D Zhang","year":"2017","unstructured":"Zhang D, Cogswell ME, Wang G, Bowman BA. Evidence of dietary improvement and preventable costs of cardiovascular disease. Am J Cardiol. 2017;120:1681\u20138.","journal-title":"Am J Cardiol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01045-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01045-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01045-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T12:57:33Z","timestamp":1678712253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-01045-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1045"],"URL":"https:\/\/doi.org\/10.1038\/s41440-022-01045-5","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"assertion":[{"value":"12 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"HS has honorarium from Daiichi-Sankyo Company, Mochida Pharmaceuticals, Astrazeneca, Novartis Pharma, Bayer, and Astellas. HS also received scholarship from Chugai and Bayer.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}